Health Centre Tešanj , Tešanj , Bosnia and Herzegovina
Department for Internal and Lung Diseases , General Hospital Tešanj , Tešanj , Bosnia and Herzegovina
Pharmaceutical Faculty of University in Sarajevo , Sarajevo , Bosnia and Herzegovina
Polyclinic for Pulmonary Diseases of Health and Educational Institution “Dr. Mustafa Šehović” Tuzla , Tuzla , Bosnia and Herzegovina
Medical School of University in Tuzla , Tuzla , Bosnia and Herzegovina
Department for Internal and Lung Diseases , General Hospital Tešanj , Tešanj , Bosnia and Herzegovina
Faculty of Health Care, University in Zenica , Zenica , Bosnia and Herzegovina
Aim
To determine an influence of alpha-lipoic acid to reduction of body weight and regulation of total cholesterol concentration,
triglycerides and glucose serum levels in obese patients with diabetes mellitus type 2.
Methods
A prospective study includes two groups of obese patients with diabetes mellitus and signs of peripheral polyneuropathia: examined group (30 patients; 15 females and 15 males), and control group (30 patients; 12 females and 18 males). All were treated with metformin (850-1700 mg/day). Examined patients were additionally treated with alpha-lipoic acid 600 mg/day during 20 weeks. Body mass index and concentrations of total cholesterol, triglycerides and glucose in serum were compared before and after the treatment.
Results
The group treated with 600 mg alpha-lipoic acid lost significantly more weight, and had lower triglyceride level than the
control group. There were no significant differences in total cholesterol and glucose serum levels between the groups.
Conclusion
Alpha-lipoic acid of 600 mg/day treatment have influenced weight and triglycerides loss in obese patients with diabetes
mellitus type 2. It should be considered as an important additive therapy in obese patients with diabetes mellitus type 2.
This work is licensed under a Attribution-NonCommercial-NoDerivatives 4.0 International 
6
Truc T. K. Le, Gabriella A. Andreani, Saleh Mahmood, Mulchand S. Patel, Todd C. Rideout
(2025)
Influence of Maternal Alpha-Lipoic Acid Supplementation on Postpartum Body Weight and Metabolic Health in Rats with Obesity
Journal of Dietary Supplements, 22(3)
10.1080/19390211.2025.2483267
Omar Alshahrani, Mohammed S Almalki
(2024)
The Efficacy of Pharmacotherapy in the Treatment of Obesity in Patients With Type 2 Diabetes: A Systematic Review
Cureus, ()
10.7759/cureus.65242
Nong Li, Weili Yan, Xiaojuan Hu, Yongdi Huang, Fugang Wang, Weiguo Zhang, Qian Wang, Xiaoling Wang, Kehong Sun
(2017)
Effects of oral α‐lipoic acid administration on body weight in overweight or obese subjects: a crossover randomized, double‐blind, placebo‐controlled trial
Clinical Endocrinology, 86(5)
10.1111/cen.13303
Nahid Najafi, Soghra Mehri, Mahboobeh Ghasemzadeh Rahbardar, Hossein Hosseinzadeh
(2022)
Effects of alpha lipoic acid on metabolic syndrome: A comprehensive review
Phytotherapy Research, 36(6)
10.1002/ptr.7406
N. V. Vorokhobina, V. L. Baranov, V. V. Kalugina, P. B. Shorokhova, V. A. Grishaeva
(2025)
An integrated approach to pathogenetic-oriented pharmacotherapy of patients with diabetes mellitus and diabetic distal polyneuropathy
Meditsinskiy sovet = Medical Council, (12)
10.21518/ms2025-289
Azam Mohamadi, Amir Reza Moravejolahkami, Gholamreza Askari, Mohammad Javad Tarrahi, Mohammadreza Hajiesmaeili, Nimah Bahreini-Esfahani
(2022)
Alpha-lipoic acid did not affect lipid profile and blood pressure in critically ill patients: A randomized, double-blind clinical trial
Mediterranean Journal of Nutrition and Metabolism, 15(3)
10.3233/MNM-211547The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.